SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 224 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $778,583 | +2.6% | 21,490 | +1.0% | 0.03% | -3.1% |
| Q4 2022 | $759,058 | -14.5% | 21,280 | -18.9% | 0.03% | -17.9% |
| Q3 2022 | $888,000 | +16.4% | 26,242 | -0.6% | 0.04% | +25.8% |
| Q2 2022 | $763,000 | -8.1% | 26,396 | +2.8% | 0.03% | -11.4% |
| Q1 2022 | $830,000 | +2.5% | 25,677 | -7.6% | 0.04% | +20.7% |
| Q4 2021 | $810,000 | -17.5% | 27,777 | -24.6% | 0.03% | -19.4% |
| Q3 2021 | $982,000 | +16.1% | 36,837 | +34.1% | 0.04% | +28.6% |
| Q2 2021 | $846,000 | +14.0% | 27,475 | -3.1% | 0.03% | +21.7% |
| Q1 2021 | $742,000 | +1.2% | 28,356 | -2.6% | 0.02% | -4.2% |
| Q4 2020 | $733,000 | +51.1% | 29,115 | +25.2% | 0.02% | +26.3% |
| Q3 2020 | $485,000 | – | 23,258 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
| ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
| S&T BANK/PA | 215,578 | $5,943 | 1.15% |
| Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
| Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
| Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
| Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
| Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |